Joanne Waldstreicher, M.D., is Chief Medical Officer at Johnson & Johnson. In this role, she has oversight across pharmaceuticals, devices and consumer products for safety, epidemiology, clinical and regulatory operations transformation, collaborations on ethical science, and technology and Research and Development (R&D) policies, including those related to clinical trial transparency and compassionate access. She chairs the R&D Pipeline Review Committee for The Janssen Pharmaceutical Companies of Johnson & Johnson, and supports the Device and Consumer Development Committees. Joanne is also a faculty affiliate of the Division of Medical Ethics, Department of Population Health, New York University School of Medicine.

Among her prior roles, Joanne was responsible for late-stage development in neuroscience, cardiovascular disease and metabolism at Janssen. Before joining Johnson & Johnson in 2002, she headed endocrinology and metabolism clinical research at Merck Research Laboratories, overseeing development programs in atherosclerosis, obesity, diabetes, urology and dermatology.

Joanne graduated summa cum laude from Brooklyn College and cum laude from Harvard Medical School. She completed her internship and residency at Beth Israel Hospital and her endocrinology fellowship at Massachusetts General Hospital. She is an active scientific author, and in 2016, the National Association of Female Executives named her Healthcare Champion of the Year. Joanne combines broad experience in science and medicine with a passion for advancing transparency and ethics, with a goal of improving the lives of patients and consumers worldwide.